Activity maintained for recombinant factor VIII modified to extend half-life: MG-1121 July 16, 2019 No Comments
Bodyweight-adjusted rivaroxaban treatment in children with acute venous thromboembolism July 15, 2019 No Comments
New CRISPR/Cas9 transgenic mice with mutated F8 gene as a model for the study of hemophilia A July 15, 2019 No Comments
BioCryst opens enrollment in phase I study of oral factor D inhibitor BCX-9930 June 28, 2019 No Comments
RSS